Literature DB >> 15538046

Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.

Sue Kyung Park1, Dong-Seok Yim, Kyung-Sik Yoon, In-Mi Choi, Ji-Yeob Choi, Keun-Young Yoo, Dong-Young Noh, Kuk-Jin Choe, Sei-Hyun Ahn, Ari Hirvonen, Daehee Kang.   

Abstract

Our previous studies suggested that both catechol O-methyl transferase (COMT) and glutathione S-transferase (GST) M1 and T1 genotypes are associated with breast cancer risk. Here we extended the studies to evaluate the potential combined effect of these genotypes in individual breast cancer risk. Incident breast cancer cases (n = 202) and controls (n = 299) with no previous cancer were recruited from three teaching hospitals in Seoul in 1996-1999. Information on putative risk factors was collected by interviewed questionnaire. PCR-based methods were used for the genotyping analyses. Odds ratios (ORs) and 95% confidence (CIs) intervals were estimated by unconditional logistic regression after adjustment for known or suspected risk factors of breast cancer. Among pre-menopausal women the low activity associated (COMT *L) allele containing genotypes and the GSTM1 null genotype posed increased risks of breast cancer with ORs of 1.7 (95% CI = 1.0 - 2.8) and 1.7 (95% CI = 1.0-2.8), respectively. A marginally significant effect of GSTT1 null genotype was also observed when the total study population was considered (OR = 1.3, 95% CI = 1.0-2.1). When the combined genotype effects were examined, the concurrent lack of GSTM1 and GSTT1 genes posed a more than 2-fold risk of breast cancer (OR = 2.2, 95% CI = 1.2-3.9); this effect was mainly attributable in pre-menopausal women (OR = 3.2, 95% CI = 1.5-7.2). Moreover, the breast cancer risk increased in parallel with the number of COMT , GSTM1 , and GSTT1 at-risk genotypes (p for trend = 0.003). This association was particularly clear in pre-menopausal women among whom combination of all three high-risk genotypes posed a 4.1-fold breast cancer risk (95% CI = 1.4-12.7) compared with pre-menopausal women without at-risk genotypes (p for trend = 0.001). The trend was more pronounced in women with BMI greater than 22 kg/m2 (p for trend < 0.001) and high-risk status of parity factor (nulliparous or women with the first full term pregnancy at age of over 25-year-old) (p for trend = 0.013). These results suggest the combined effect between reproductive factors and GSTM1, GSTT1 and COMT genotypes in human breast carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15538046     DOI: 10.1007/s10549-004-0745-x

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  12 in total

1.  Genetic polymorphisms in the catechol estrogen metabolism pathway and breast cancer risk.

Authors:  Kerryn W Reding; Noel S Weiss; Chu Chen; Christopher I Li; Christopher S Carlson; Hui-Wen Wilkerson; Federico M Farin; Kenneth E Thummel; Janet R Daling; Kathleen E Malone
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-04-21       Impact factor: 4.254

2.  Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women.

Authors:  Lori C Sakoda; Christie R Blackston; Kan Xue; Jennifer A Doherty; Roberta M Ray; Ming Gang Lin; Helge Stalsberg; Dao Li Gao; Ziding Feng; David B Thomas; Chu Chen
Journal:  Breast Cancer Res Treat       Date:  2007-07-12       Impact factor: 4.872

3.  Meta-analysis of genetic polymorphisms in xenobiotic metabolizing enzymes and their association with breast cancer risk.

Authors:  Tajamul Hussain; Salman Alrokayan; Upadhyay Upasna; Manickam Pavithrakumari; Jaganathan Jayapriya; Vijay Kumar Kutala; Shaik Mohammad Naushad
Journal:  J Genet       Date:  2018-06       Impact factor: 1.166

4.  Association of glutathione S-transferase T1, M1 and P1 polymorphisms in the breast cancer risk: a meta-analysis in Asian population.

Authors:  Jianqiu Tang; Qiaoxia Zhou; Fen Zhao; Fulin Wei; Jian Bai; Yuping Xie; Ying Huang
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms.

Authors:  Wei Yue; Ji-Ping Wang; Yuebai Li; Ping Fan; Guijian Liu; Nan Zhang; Mark Conaway; Hongkun Wang; Kenneth S Korach; Wayne Bocchinfuso; Richard Santen
Journal:  Int J Cancer       Date:  2010-10-15       Impact factor: 7.396

6.  Impact of xenobiotic-metabolizing gene polymorphisms on breast cancer risk in South Indian women.

Authors:  Taruna Rajagopal; Arun Seshachalam; Krishna Kumar Rathnam; Arunachalam Jothi; Srikanth Talluri; Sivaramakrishnan Venkatabalasubramanian; Nageswara Rao Dunna
Journal:  Breast Cancer Res Treat       Date:  2021-01-04       Impact factor: 4.872

7.  Combined effect of CYP1B1, COMT, GSTP1, and MnSOD genotypes and risk of postmenopausal breast cancer.

Authors:  Jasmina-Ziva Cerne; Maja Pohar-Perme; Srdjan Novakovic; Snjezana Frkovic-Grazio; Vida Stegel; Ksenija Gersak
Journal:  J Gynecol Oncol       Date:  2011-06-30       Impact factor: 4.401

8.  Risk factors and control strategies for the rapidly rising rate of breast cancer in Korea.

Authors:  Sue K Park; Yeonju Kim; Daehee Kang; En-Joo Jung; Keun-Young Yoo
Journal:  J Breast Cancer       Date:  2011-06-18       Impact factor: 3.588

9.  Departure from multiplicative interaction for catechol-O-methyltransferase genotype and active/passive exposure to tobacco smoke among women with breast cancer.

Authors:  Brian D Bradbury; Jemma B Wilk; Ann Aschengrau; Timothy L Lash
Journal:  J Carcinog       Date:  2006-01-17

Review 10.  Association of COMT Val158Met polymorphism and breast cancer risk: an updated meta-analysis.

Authors:  Xue Qin; Qiliu Peng; Aiping Qin; Zhiping Chen; Liwen Lin; Yan Deng; Li Xie; Juanjuan Xu; Haiwei Li; Taijie Li; Shan Li; Jinmin Zhao
Journal:  Diagn Pathol       Date:  2012-10-08       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.